Tulathromycin A inhibits protein synthesis by targeting bacterial ribosomes (IC50=0.26 µM). It has immunomodulatory effect.
Tulathromycin A inhibits protein synthesis by targeting bacterial ribosomes (IC50=0.26 µM). It has immunomodulatory effect.
Tulinercept (OPRX-106) is an orally available recombinant fusion protein targeting TNF for studies related to ulcerative colitis (UC). Tulinercept is a TNF-α inhibitor.
Tulmimetostat is an orally active dual EZH1/EZH2 protein inhibitor with antitumor activity for use in a variety of solid tumor studies.
Tulmimetostat is an orally active dual EZH1/EZH2 protein inhibitor with antitumor activity for use in a variety of solid tumor studies.
Tulobuterol (C-78 free base) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma.
Tulobuterol (C-78 free base) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma.
Tunicamycin is a mixture of nucleoside antibiotics that inhibits N-glycosylation and blocks GlcNAc phosphotransferase (GPT).
Tunicamycin is a mixture of nucleoside antibiotics that inhibits N-glycosylation and blocks GlcNAc phosphotransferase (GPT).
Tunicamycin is a mixture of nucleoside antibiotics that inhibits N-glycosylation and blocks GlcNAc phosphotransferase (GPT).
Tussilagone is a major active component in Tussilago farfara, has anti-inflammatory effect.